When a nucleoside analogue prodrug, like ganciclovir, is administered systemically to tumour cells after adenoviral transduction of HSV-tk, it phosphorylates the prodrug, stops DNA replication, and causes cell death in proliferating tumour cells as well as nearby cells through the bystander effect. Here, TKT is linked to neoplasm.